News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) has awarded 10% owner Barry Canton a total of 319,332 restricted stock units (RSUs) on July 28, 2026. These RSUs cover Class A Common Stock, with some vesting 75% on October 16, 2026, and 25% on January 21, …
Sharemaestro market context Price above Trend Line 52 weeks -28.3% · Next-week setup negative 4.8%Ginkgo Bioworks Holdings, Inc. CEO Jason R. Kelly was granted two awards of restricted stock units (RSUs) on July 28, 2026. One grant is for 74,258 RSUs, vesting 75% on October 16, 2026, and 25% on January 21, 2027. The second grant is for …
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 7.7% in Ginkgo Bioworks Holdings, Inc. Class A stock. This amounts to 4,122,510 shares, with BlackRock's reporting business units holding sole voting power over 4,013,128 shares and sole dispositive power over …
Bernstein Liebhard LLP reminds investors of the January 18, 2022, deadline to file a lead plaintiff motion in a securities class action lawsuit against Ginkgo Bioworks Holdings, Inc. The lawsuit, filed in the United States District Court for the Northern District of California, alleges …
This article first appeared on GuruFocus. Assets Under Management (AUM): Reached a record high of EUR1.19 trillion, with an increase of almost EUR100 billion in Q2. Earnings Per Share (EPS): EUR1.19 for Q2, totaling EUR2.51 for the first half of the year. Revenue: EUR773 …
Sharemaestro market context Trend signal active 52 weeks +34.9% · Next-week setup positive 62.9%Stellantis has reached an agreement to sell its entire stake in the car-sharing division Free2move to Mutares, a German private equity firm. Free2move, founded in 2016, runs short- and long-term free-floating fleets in 14 cities spanning Europe and the US. According to the press …
Ginkgo Bioworks Holdings, Inc. Class A (9L40) reported revenues of €144.87 million last year, with the Cell Engineering segment contributing the most at €113.02 million. This was a decrease from the previous year's €168.
Evinova's full Study Designer with AI suite will be leveraged by Merck KGaA, Darmstadt, Germany to shape future product innovations and accelerate industry-wide transformation BAAR, Switzerland, July 29, 2026--(BUSINESS WIRE)--Evinova, a global leader in AI-native clinical development technology, today announced a new multi-year strategic …
Sharemaestro market context Trend signal active 52 weeks +24.0%STELLANTIS N.V. Stellantis Announces Agreement to Sell Free2move's Car-sharing Business to Mutares Free2move provides free-floating car-sharing services in Europe and the United States Stellantis will prioritize continuity for customers, partners, and employees throughout the process, expected to close by the end of 2026 Amsterdam/Munich, …
Company Logo Disposables lead the product segment, while plasmapheresis holds the largest procedure share. North America dominates the market. Key players include Terumo, Fresenius, Haemonetics, BD and B. Braun. Apheresis MarketApheresis Market Dublin, July 24, 2026 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product, …
This article analyzes Ginkgo Bioworks Holdings Inc. Class A (NYSE: DNA), highlighting weak sentiment across all horizons supporting a short bias. It details an exceptional 126.0:1 risk-reward setup targeting a 34.9% gain versus 0.3% risk. The analysis provides three institutional trading strategies (Position, Momentum …
Merck KGaA (MKKGY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks …
Sharemaestro market context Trend signal active 52 weeks +24.0%Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, perhaps …
Sharemaestro market context Trend signal active 52 weeks +24.0%Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Henkel KGaA has delivered a 15.6% total return over the past three years, while its current valuation checks still suggest the stock leans …
Sharemaestro market context Trend signal active 52 weeks +6.7%Ginkgo Bioworks (NYSE: DNA) CFO Steven P. Coen reported the vesting of 1,486 restricted stock units (RSUs) on July 16, 2026. Following this, he sold 752 shares of Class A Common Stock on July 17, 2026, at $7.903 per share. This sale was a …
Sharemaestro market context Price above Trend Line 52 weeks -28.3% · Next-week setup negative 4.8%The 13-agent catalog is built on a shared foundation, so each agent you deploy makes the next one faster and cheaper. ZURICH, July 20, 2026 /PRNewswire/ -- Squirro, the enterprise AI company whose customers include central banks and global manufacturers such as Deutsche Bundesbank …
Sharemaestro market context Trend signal active 52 weeks +6.7%Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Merck KGaA's MilliporeSigma unit has opened a new BioReliance testing facility in Darmstadt, Germany, expanding its biopharmaceutical testing footprint in Europe. The company reported a …
Sharemaestro market context Trend signal active 52 weeks +24.0%Ginkgo Bioworks insider Steve Coen has filed a Form 144 notice to sell 752 Class A common shares through Fidelity Brokerage Services. These shares originated from restricted stock vesting as compensation. The filing also reports previous Class A stock sales by Coen on April …
Sharemaestro market context Price above Trend Line 52 weeks -28.3% · Next-week setup negative 4.8%Search by ticker symbol or company name and select a result to open its chart.